Can a Chinese company's powerful new genome sequencer compete in the U.S.?

Can a Chinese company's powerful new genome sequencer compete in the U.S.?

A Chinese company unveils a powerful new sequencer. But can it compete in the U.S.? By REBECCA ROBBINS AND KATE SHERIDAN ANDREW WONG/GETTY IMAGES The company, BGI, could shape up as a very fierce competitor for Illumina — and possibly drive the already-plummeting cost of sequencing down even further. READ MORE